drugset / Trial / NCT01101867

Prandial Insulin Dosing in Hospitalized Patients

NCT01101867

Phase 4 Completed 126 enrolled Kathleen Dungan Novo Nordisk A/S · collab
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to determine whether mealtime insulin results in better control of blood sugar than a fixed meal dose in hospitalized patients.

Timeline

Start
2010-06
Primary completion
2012-06
Completion
2013-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator insulin aspart Protein / enzyme biologic

Indications